- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06358924
Effect of Different Desensitizing Agents on Post-bleaching Hypersensitivity and Shade Stability
The Effect of Different Desensitizing Agents on Post-bleaching Hypersensitivity, Shade Stability and Surface Properties of Bleached Enamel. An In-vitro and In-vivo Study.
Study Overview
Status
Conditions
Detailed Description
This study was conducted to assess the effectiveness of 4 different desensitizing agents used after dental bleaching regarding dental hypersensitivity and shade stability. It was a double-blinded randomized clinical trial.
The ethical approval was obtained in May 2020 by the Research Ethics Committee an Institutional Review Board, Faculty of Dentistry, Ain Shams University (FDASU-REC).
The number of patients was determined according to G-Power program with a power (1-β error) of 0.8 (Power = 80%), and 95% confidence level (α = 0.05) using a two-sided hypothesis test. According to sample size calculation, 40 patients were needed for this study (n=10 per group).
Patients were selected according to inclusion and exclusion criteria and were randomly assigned into 4 groups according to the desensitizing agent used. The 4 desensitizing agents were: After Whitening Mousse, Mi Paste Plus, Hydroxyapatite and Fluoride (ReminPro) and PAMAM.
Patients signed an informed consent and received a detailed explanation of the study procedures. Baseline dental shade was recorded using Vita Easy-Shade spectrophotometer and Vita Classical Shade guide. Baseline sensitivity was assessed and recorded using a VAS.
All patients received dental bleaching using In-office chemically activated Power Whitening YF (WHITEsmile, Germany) followed by a desensitizing procedure using the desensitizing agent assigned to the specific experimental group.
Dental shade and dental hypersensitivity was assessed at different follow-up appointments; 24-hours, 3 days, 1 week, 1 month, 3 months, 6 months, 9 months and 1 year following the procedures.
Assessment of these variables at follow-up appointments was performed by 2 external assessors, and patients were blinded to the type desensitizing agent used.
Study Type
Enrollment (Actual)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
El Weilli
-
Cairo, El Weilli, Egypt, 4393005
- faculty of dentistry, Ain shams university
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants with their entire upper and lower teeth, from right first premolar to left first premolar, present and sound, without restorations or periodontal disease.
- The participants had low-caries index scores.
- Participants had teeth with a Vita-color shade of A2 or darker.
- Cooperative behavior patient and medically free.
- Patient ages between 18 to 40 years old
Exclusion Criteria:
- Serious medically compromised patients.
- Smoking, alcoholism.
- Hypersensitivity to the agents used in the study.
- Lactating, pregnant patients.
- Patients with serious oral diseases, as acute necrotizing gingivitis, acute gingiva stomatitis, or those undergoing orthodontic treatment.
- Patients with dental enamel cracks.
- Patients who've had previous bleaching treatments
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: After whitening mousse
30 % Xylitol, 4.2 % potassium nitrate, and 1450 ppm fluoride.
Topical tooth gel Gel was applied on bleached teeth for 10 minutes according to manufacturer's instructions.
|
Bleaching of teeth using in-Office chemically-activated bleaching agent (Power Whitening YF) was performed followed by the application of the desensitizing agent recommended by the manufacturer (After Whitening Mousse), once for 10 minutes.
|
Experimental: PAMAM "poly (amido amine)" dendrimer
PAMAM-succinamic acid dendrimer, 1,4-diaminobutane core, generation 4 solution.
10 wt.% in water Colorless liquid The liquid was applied on bleached teeth for 30 minutes (according to previous studies)
|
Bleaching of teeth using in-Office chemically-activated bleaching agent (Power Whitening YF) was performed followed by the application of PAMAM once for 30 minutes.
|
Experimental: Mi Paste Plus
Casein-phosphopeptide-amorphous calcium phosphate with 0.2 % sodium fluoride (900ppm) Topical tooth cream Cream was applied on bleached teeth for 3 minutes according to manufacturer's instructions
|
Bleaching of teeth using in-Office chemically-activated bleaching agent (Power Whitening YF) was performed followed by the application of Mi Paste Plus once for 3 minutes.
|
Experimental: Hydroxyapatite and Fluoride (ReminPro)
Hydroxyapatite (calcium and phosphate), ethanolic colophony, fluoride (1450 ppm NaF) and xylitol Topical water based tooth cream Cream was applied on bleached teeth for 3 minutes according to manufacturer's instructions
|
Bleaching of teeth using in-Office chemically-activated bleaching agent (Power Whitening YF) was performed followed by the application of Hydroxyapatite and Fluoride (ReminPro) once for 3 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-bleaching hypersensitivity
Time Frame: 24 hours, 3 days, 7 days, 1 month, 3 months, 6 months, 9 months and one year post bleaching
|
Assessment was carried out by a visual analogue scale (VAS), from 0 (no tooth sensitivity at all) to 10 (intolerable pain). The air stimulus was applied at a distance of 0.5-1 cm for 2 seconds by the maximum power of the compressed air jet from the dental unit. Then patients were asked to describe the intensity of pain by numbers from 1 to 10. Sensitivity was measured before bleaching (baseline) and at each follow up period, 24 hours, 3 days, 7 days, 1 month, 3 months, 6 months, 9 months and one year post bleaching. |
24 hours, 3 days, 7 days, 1 month, 3 months, 6 months, 9 months and one year post bleaching
|
Shade stability
Time Frame: 24 hours, 3 days, 7 days, 1 month, 3 months, 6 months, 9 months and one year post bleaching
|
Assessment was carried out using Vita Easy-Shade V. Two measurements were taken for each tooth from the upper right canine to the upper left canine, and same for the lower arch. For light condition standardization, all shade measurements were carried out under natural daylight in combination with constant artificial light sources; the clinic overhead lights in combination with the dental unit light directed away from the patient. The shade of each tooth was recorded as well as the values of L, a, and b. The shade of the upper two centrals was confirmed using Vita classical shade guide. Shade assessment was carried out before bleaching, and at each follow up period, 24 hours, 3 days, 7 days, 1 month, 3 months, 6 months, 9 months and one year post bleaching. |
24 hours, 3 days, 7 days, 1 month, 3 months, 6 months, 9 months and one year post bleaching
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Farid MS El-Askary, Professor, faculty of dentistry, Ain shams university
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Immune System Diseases
- Stomatognathic Diseases
- Tooth Diseases
- Hypersensitivity
- Dentin Sensitivity
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Protective Agents
- Calcium-Regulating Hormones and Agents
- Cariostatic Agents
- Chelating Agents
- Sequestering Agents
- Calcium
- Fluorides
- Caseins
Other Study ID Numbers
- FDASU-RecID032004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tooth Hypersensitivity
-
Khon Kaen UniversityCompletedDentine Hypersensitivity | Tooth ErosionThailand
-
Cairo UniversityCompletedHypersensitivity Dentin | Tooth HypersensitivityEgypt
-
Federal University of UberlandiaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...UnknownDentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity DentinBrazil
-
Cairo UniversityUnknown
-
Dentsply InternationalCompletedTooth HypersensitivityUnited States
-
Dentsply InternationalCompletedTooth HypersensitivityUnited States
-
Federal University of UberlandiaCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Fundação de Amparo...UnknownDentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity DentinBrazil
-
Ain Shams UniversityCompleted
-
National Research Centre, EgyptCompletedTooth HypersensitivityEgypt
-
Federal University of UberlandiaCompletedDentin Sensitivity | Dentin Hypersensitivity | Dentine Hypersensitivity | Hypersensitivity DentinBrazil
Clinical Trials on Potassium nitrate with fluoride
-
GlaxoSmithKlineCompleted
-
Universidade Federal do AmazonasCompleted
-
Johnson & Johnson Consumer and Personal Products...CompletedDentin SensitivityUnited States
-
University of PennsylvaniaCompleted
-
University of PennsylvaniaNorthwestern UniversityCompleted
-
University of PennsylvaniaCompletedHeart Failure | Diastolic Heart FailureUnited States
-
GlaxoSmithKlineCompletedDentin SensitivityUnited States
-
Washington University School of MedicineActive, not recruitingHeart FailureUnited States
-
GlaxoSmithKlineCompletedDentin Sensitivity | Dentin HypersensitivityCanada
-
GlaxoSmithKlineCompletedDentine HypersensitivityUnited States